Emergen Research Logo. The diabetic foot ulcer treatment market is expected to grow from an estimated USD 5.36 Billion in 2024 to USD 9.21 Billion in 2033, ...
Use of SGLT2 inhibitors was associated with improved kidney health among a diverse multiethnic cohort of Asian adults with type 2 diabetes, researchers found in a retrospective cohort study.
Diabetic nephropathy is the leading cause of kidney disease in patients starting renal replacement therapy and affects ~40% of type 1 and type 2 diabetic patients. It increases the risk of death ...